Ernexa Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 05/14/2026 | 2.00 M | $398.00 K | 100.00% | 10.10% |
| DAUNTLESS INVESTMENT GROUP, LLC | 05/14/2026 | 612.44 K | $121.88 K | 100.00% | 3.09% |
| CI PRIVATE WEALTH, LLC | 05/15/2026 | 438.09 K | $87.18 K | 0.00% | 2.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 244.45 K | $48.64 K | 935.04% | 1.23% |
| XTX TOPCO LTD | 05/15/2026 | 54.34 K | $10.81 K | 100.00% | 0.27% |
| WARBERG ASSET MANAGEMENT LLC | 05/07/2026 | 50.00 K | $10.06 K | 100.00% | 0.25% |
| JANE STREET GROUP, LLC | 05/12/2026 | 41.17 K | $8.19 K | 100.00% | 0.21% |
| CITADEL ADVISORS LLC | 05/15/2026 | 33.08 K | $6.58 K | 100.00% | 0.17% |
| 05/15/2026 | 26.50 K | $5.27 K | 100.00% | 0.13% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 25.45 K | $5.06 K | 100.00% | 0.13% |
| UBS GROUP AG | 05/05/2026 | 21.23 K | $4.23 K | 3,438.83% | 0.11% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 16.63 K | $3.31 K | 100.00% | 0.08% |
| SIPPICAN CAPITAL ADVISORS | 04/23/2026 | 10.00 K | $1.99 K | 0.00% | 0.05% |
| BLACKROCK, INC. | 05/13/2026 | 820 | $163 | 0.00% | 0.00% |
| ASSETMARK, INC | 05/06/2026 | 133 | $26 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 10 | $2 | 0.00% | 0.00% |
| MONTAG A & ASSOCIATES INC | 04/29/2026 | 8 | $2 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 6 | $1 | 100.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 04/15/2026 | 3 | $1 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 04/16/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ernexa Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Ernexa Therapeutics Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 2 M
Dauntless Investment Group, LLC: 612,443
CI Private Wealth, LLC: 438,093
GEODE CAPITAL MANAGEMENT, LLC: 244,446
XTX Topco Ltd: 54,338
Warberg Asset Management LLC: 50,000
18.05% of Ernexa Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.60 M shares in the last 24 months. This purchase volume represents approximately $1.01 M in transactions.